Hadean Ventures invests in European life science startups that leverage cutting-edge science to solve critical healthcare problems. The firm prioritizes high-impact solutions across rare diseases, oncology, digital health, and other underserved areas, aiming to generate strong financial returns while driving meaningful societal impact.
Preferred startup development maturity for initial funding deployment.
Science-driven innovation in healthcare, addressing unmet medical needs and complex real-world challenges through advanced biotech, digital therapeutics, and medical devices.
Core thematic spaces, technologies, and target market segments of interest.
Standard financial allocation per investment round.
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...